Nigeria to launch mass polio immunization drive

By Tume Ahemba

LAGOS (Reuters) - Nigeria will launch a new campaign to vaccinate millions of children against polio Wednesday in an attempt to curb the spread of the disease that has crippled hundreds this year, the World Health Organization said.

Africa’s most populous country, which accounts for more than 50 percent of new polio cases in the world, has struggled to tame the contagious disease since some states in the mainly Muslim north imposed a year-long vaccine ban in mid-2003.

New polio infections in Nigeria have climbed 225 percent to 751 this year from the same period last year because many children in the north missed several rounds of immunization toward the end of 2007, health officials said.

The immunization drive runs until November 30 in 17 northern states and from December 10-12 for the rest of the country.

“The challenge is now for all stakeholders to ensure that all eligible children in Nigeria are indeed taken to the vaccination posts … to receive these vaccines and supplements,” WHO said in a notice.

Children need multiple doses of the oral vaccine to develop full immunity to the incurable infection.

The Nigerian government has set up a presidential task force to bolster the national immunization effort.

Only four countries — Nigeria, India, Pakistan and Afghanistan — remain endemic for the disease that spreads through poor hygiene.

Nigeria has come under pressure to boost immunization since May when neighboring Benin reported its first infection in four years. The virus had first spread to Nigeria’s northern neighbors Chad and Niger, WHO said.

Polio, which can cause permanent paralysis in children, can be prevented with vaccines that have eliminated the virus as a public health threat in most parts of the world.

The global polio eradication initiative, run by WHO, UNICEF, Rotary International and the United States Centers for Disease Control and Prevention, has spent more than $6 billion to fight the scourge in the remaining affected countries.

One major setback was the suspension of immunization in northern Nigeria in 2003, when Muslim leaders told parents that the vaccines could endanger their children.

(Reporting by Tume Ahemba; Editing by Randy Fabi and Giles Elgood)


Related Posts:

By Gene Emery BOSTON (Reuters) - A newer vaccine that targets the most common form of the polio virus works up to four times better than the conventional vaccine that tries to protect against all three types of the crippling disease, researchers said on Wednesday. The monovalent vaccine may help speed the fight to eradicate polio, U.S.

Full Post: Newer vaccine seen as better for polio hot spots

By Will Dunham WASHINGTON (Reuters) - An infusion of more than $630 million spearheaded by Microsoft co-founder Bill Gates is intended to help finish the job of eradicating the crippling disease polio, officials said on Wednesday. The Seattle-based Bill & Melinda Gates Foundation and the Rotary International charity joined with the governments of Britain and Germany to

Full Post: Bill Gates, others pledge $630 million to beat polio

BANGALORE, India (Reuters) - Thousands of parents and their children protested outside hospitals in the southern Indian city of Bangalore following false rumors that children had fallen sick after being given polio drops, police said on Monday. Police said nobody had fallen ill from the vaccine and filed a complaint against a local TV station, saying

Full Post: Rumors spark polio vaccine panic in south India

WASHINGTON (Reuters) - Smokers should be vaccinated against a pneumonia-causing germ, along with children and the elderly, U.S. federal advisers recommended on Wednesday. If accepted by the Centers for Disease Control and Prevention, it would be the first vaccine recommendation aimed specifically at smokers. The vaccines, called pneumococcal vaccines, prevent infection with several strains of Streptococcus pneumonia,

Full Post: Smokers should get pneumonia vaccine: U.S. advisers

By Maggie Fox, Health and Science Editor WASHINGTON (Reuters) - An experimental malaria vaccine is the most promising yet, protecting up to 65 percent of infants from infection in two studies in Africa, researchers reported on Monday. Separate tests in Kenya and Tanzania showed GlaxoSmithKline’s vaccine called RTS,S could protect babies and toddlers from infection with malaria

Full Post: Glaxo malaria vaccine protects babies, children

Site Navigation

Most Read